Markus Rey

A Novel Genomic Signature with Translational Significance for Human Idiopathic Pulmonary Fibrosis

Yasmina Bauer, John Tedrow, Simon de Bernard et al. · American Journal of Respiratory Cell and Molecular Biology · 2014 · 191 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

The Discovery of <i>N</i>-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-<i>N</i>′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist

Martin H. Bolli, Christoph Boss, Christoph A. Binkert et al. · Journal of Medicinal Chemistry · 2012 · 148 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Pharmacology of the Urotensin-II Receptor Antagonist Palosuran (ACT-058362; 1-[2-(4-Benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea Sulfate Salt): First Demonstration of a Pathophysiological Role of the Urotensin System

Martine Clozel, Christoph A. Binkert, Magdalena Birker et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 132 citations · Full text

Medicine, Pharmacology, Molecular Pharmacology +12

Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats.

Martine Clozel, Patrick Hess, Markus Rey et al. · PubMed · 2006 · 94 citations

Medicine, Pharmacology, Pharmacotherapy +16

The Urotensin-II Receptor Antagonist Palosuran Improves Pancreatic and Renal Function in Diabetic Rats

Martine Clozel, Patrick Hess, Changbin Qiu et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 90 citations

Medicine, Endocrinology, Pharmacology +17